Timothy A. Springer - 02 Jul 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role: Director, 10%+ Owner
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Issuer symbol: RNAC
Transactions as of: 02 Jul 2024
Net transactions value: +$47,190,000
Form type: 4
Filing time: 05 Jul 2024, 16:02:09 UTC
Previous filing: 24 Jun 2024
Next filing: 14 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNAC	Series B Non-Voting Convertible Preferred Stock	Award	$32,736,640	+1,636,832		$20.00	1,636,832	02 Jul 2024	Direct
transaction	RNAC	Series B Non-Voting Convertible Preferred Stock	Award	$14,427,220	+721,361		$20.00	721,361	02 Jul 2024	See Footnote	F1
transaction	RNAC	Series B Non-Voting Convertible Preferred Stock	Award	$26,140	+1,307		$20.00	1,307	02 Jul 2024	By wife
holding	RNAC	Common Stock						4,379,899	02 Jul 2024	Direct
holding	RNAC	Common Stock						1,927,630	02 Jul 2024	See Footnote	F1
holding	RNAC	Common Stock						3,493	02 Jul 2024	By wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.